KELLY MYERS: Open Payments
NPI 1164009395 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$297 in 12 payments from 9 companies in 2025. Trend: 2023 $15 · 2024 $191 · 2025 $297
Food & beverage: $297
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 1 | $86 |
| Novo Nordisk Inc | 2 | $48 |
| ABBVIE INC. | 2 | $39 |
| Amgen Inc. | 2 | $37 |
| Dexcom, Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Edwards Lifesciences Corporation | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
| Organon LLC | 1 | $13 |
Products named: APRETUDE, Wegovy, VRAYLAR, OTEZLA, Dexcom G6 Transmitter, CAPVAXIVE, SAPIEN 3 Ultra RESILIA, MOUNJARO.
Industry payments across SC — which companies pay providers there.
